Automated Left Ventricular Function Evaluation by LVivoEF
Launched by DIA IMAGING ANALYSIS LTD · Jan 23, 2012
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
LVivoEF is a decision support system (software) for automated global left ventricle (LV) systolic function evaluation from echocardiographic examinations. LVivoEF technology is based on a novel image processing algorithm for LV edge detection and ejection fraction (EF) evaluation. LVivoEF provides fully automated measurements of the left ventricle (LV) from two apical views the four chamber (4CH) and the two chamber (2CH).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Patients referred to an echocardiographic examination. The patients will be consecutive until 30% of patients with normal LV function are enrolled. After that only consecutive patients with abnormal LV function will be included.
- Exclusion Criteria:
- • Examinations in which more than one third of the endocard is not visible in a plane (2CH/4CH)
- • Patients with Left bundle branch block (LBBB)
About Dia Imaging Analysis Ltd
Dia Imaging Analysis Ltd. is a pioneering company dedicated to advancing medical imaging technologies and enhancing diagnostic accuracy through innovative analysis solutions. With a focus on developing cutting-edge software and algorithms, the company aims to streamline the interpretation of medical images, facilitating improved patient outcomes in clinical settings. Committed to research and collaboration, Dia Imaging Analysis Ltd. plays a vital role in clinical trials, supporting the evaluation of new therapies and diagnostic tools while adhering to the highest standards of regulatory compliance and scientific integrity. Their expertise in imaging analysis positions them as a key partner in the evolving landscape of healthcare innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beer Sheva, , Israel
Patients applied
Trial Officials
Noah Liel-Cohen, MD
Principal Investigator
Soroka University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials